Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus Pharmaceutical Investing
Solarvest Signs Agreements with OrgHive, China’s Leading Organic Blockchain Verified Digital E-Commerce Platform Pharmaceutical Investing
Merck and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOVe-AHEAD Study Evaluating Molnupiravir for Post-Exposure Prophylaxis of COVID-19 Infection Pharmaceutical Investing
FDA Approves Updated Indication for Merck's KEYTRUDA® for Treatment of Certain Patients With Urothelial Carcinoma Pharmaceutical Investing
Outcry Continues to Grow for Johnson & Johnson to Resolve Talc-Cancer Claims After Latest Jury Verdict Medical Device Investing
Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa Medical Device Investing
Solarvest BioEnergy: Producing The World’s Only Plant-based Organic Certified Omega -3 Pharmaceutical Investing
Late-Breaking Data Shows Abbott's Amplatzer Amulet Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman? Device for People With Atrial Fibrillation at Risk of Stroke Medical Device Investing
Positive Top-Line Results From Pfizer's Phase 3 JADE DARE Trial Comparing the Efficacy of Abrocitinib and Dupilumab for Moderate to Severe Atopic Dermatitis Pharmaceutical Investing
